Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis (EOS-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02493335
Recruitment Status : Active, not recruiting
First Posted : July 9, 2015
Last Update Posted : January 31, 2020
Sponsor:
Information provided by (Responsible Party):
Dr. Falk Pharma GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 28, 2018
Estimated Study Completion Date : December 2020